Aarti Pharmalabs Limited — Financials & Forensics
Sector: Healthcare · NSE: AARTIPHARM · BSE: 543748 · ISIN: INE0LRU01027
18 Aug 2026
Add AARTIPHARM to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY23 | FY24 | FY26 |
|---|---|---|---|
| Revenue from operations | ₹1,945 Cr | ₹1,853 Cr | ₹1,819 Cr |
| EBITDA | ₹342 Cr | ₹386 Cr | ₹369 Cr |
| EBITDA margin | 17.6% | 20.8% | 20.3% |
| Profit after tax | ₹193 Cr | ₹217 Cr | ₹175 Cr |
Deeper analysis
Recent filings by Aarti Pharmalabs Limited
-
Newspaper Publication on Financial Results
09 Aug 2026 · Regulatory Compliance
-
As enclosed
07 Aug 2026 · Management Change
-
Outcome of Board Meeting held on August 07, 2026.
07 Aug 2026 · Financial Results
Never miss a filing again
About Aarti Pharmalabs Limited on Indian Stock Alerts
Indian Stock Alerts tracks Aarti Pharmalabs Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.